Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Hepatic Function

NCT07682818 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.

NCT NCT07682818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07682818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Hepatic Function
Lead sponsor
Zealand Pharma
Phase
Phase 1
Overall status
Recruiting
Start date
May 18, 2026
Completion date
April 12, 2027
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

impaired hepatic function